Weight-Loss Drugs Outperform Older Diabetes Pills in People with HIV, Real-World Study Finds
A nine-site U.S. cohort study found that GLP-1 receptor agonists produced roughly four times more weight loss than SGLT2 inhibitors ...
A nine-site U.S. cohort study found that GLP-1 receptor agonists produced roughly four times more weight loss than SGLT2 inhibitors ...
A large real-world study finds once-weekly semaglutide outperforms sulfonylureas, DPP4 inhibitors, and thiazolidinediones on blood sugar, weight, blood pressure, and ...
The first systematic review and meta-analysis of GLP-1 receptor agonist use in body contouring surgery finds a possible wound dehiscence ...
A retrospective study from the University of Palermo links type 2 diabetes to worse hearing thresholds and finds that GLP-1 ...
A meta-analysis of 19 high-potency incretin trials finds that objective signs of malnutrition and lean mass loss occur far more ...
A comparative narrative review finds tirzepatide delivers the largest HbA1c and weight reductions among incretin therapies, while semaglutide leads on ...
A perspective in npj Sustainable Agriculture examines how rapidly spreading appetite-suppressing drugs could reshape food demand, agriculture and environmental outcomes.
A comprehensive review in Nature Reviews Neurology details how obesity damages the hypothalamus, hippocampus and cerebrovasculature to drive cognitive decline, ...
A decade-spanning review of 179 studies reveals that more than half of Malaysian adults are overweight or obese, while the ...
A new commentary urges caution in interpreting a reported link between GLP-1 receptor agonist use and wound dehiscence after body ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine